December 15th, 2022 | 🕒
https://www.ispeech.org/text.to.speech The company said the license is an important milestone for the facility, which is located in northwestern France, continuing
December 12th, 2022 | 🕒
https://www.ispeech.org/text.to.speech Seattle, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO),
October 14th, 2022 | 🕒
https://www.ispeech.org/text.to.speech DUBLIN--(BUSINESS WIRE)--The "Antibody Library Technology Market Analysis, by Technology, by Application, by End User, and by Region - Global
September 2nd, 2022 | 🕒
iSpeech Spear Bio Recognized by AACC for "Best Abstract in Metabolomics" Poster WOBURN, Mass., Sept. 2, 2022 /PRNewswire/ -- Developer
August 4th, 2022 | 🕒
iSpeech.org In a recent study posted to the medRxiv* preprint server, researchers conducted an observational trial in the United States
June 6th, 2022 | 🕒
Text to Speech Demo This article includes research findings that are yet to be peer-reviewed. Results are therefore regarded as
April 21st, 2022 | 🕒
https://www.ispeech.org/text.to.speech For nearly 40 years, drugmakers have used genetically engineered cells as tiny drug factories. Such cells can be programmed
April 14th, 2022 | 🕒
iSpeech.org VICTORIA, British Columbia, April 14, 2022--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA) (TSXV: IPA) is
March 22nd, 2022 | 🕒
iSpeech.org Santa Fe-based Specifica has been awarded two U.S. patents for its "antibody libraries with maximized antibody developability characteristics." Specifica
March 2nd, 2022 | 🕒
iSpeech An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many
January 10th, 2022 | 🕒
iSpeech.org DUBLIN--(BUSINESS WIRE)--The "Antibody Drug Conjugate Market Research Report by Mechanism of Action, by Drugs, by Technology, by Application, by
December 7th, 2021 | 🕒
Powered by iSpeech Software is key to how therapeutic antibodies are discovered today. The founders of Nabla Bio say
October 21st, 2021 | 🕒
text to speech Clinical-stage biopharma company F-star Therapeutics announced a new partnership with Janssen Biotech on Wednesday, only one month
September 30th, 2021 | 🕒
TTS SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs
Gloss